The most respected names in law are those who lead with clarity, strategy, and an unwavering sense of purpose. These ...

Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK ; Company has achieved two consecutive qu ...

A county vote on a state conservatorship expansion law got lots of attention from local hospitals, activists and San Diego ...

A poster was presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL in June titled “Phase 2 trial of Ozuriftamab Vedotin (BA3021), a Conditionally Binding ...

An exclusive interview with Serge Saxonov of 10x Genomics and Giovanna Prout of Scale Biosciences on what the acquisition means for single cell genomics.

Ameren Illinois’ Central Illinois Grid Transformation Program will add 380 miles of 345-kV lines and three new substations, ...

Thank you, operator, and good afternoon, everyone. We thank you for joining us for the call for INmune Bio's second quarter 2025 financial results. Presenting on today's call are David Moss, ...

August 6, 2025The GEO Group, Inc. beats earnings expectations. Reported EPS is $0.2072, expectations were $0.16. Operator: ...

SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...

Cash runway into Q2 2027, with cash, cash equivalents, and investments of $142.4 million as of June 30, 2025 ...

Pacira BioSciences, Inc. ( NASDAQ: PCRX) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Brendan P. Teehan - Chief Commercial Officer Frank D. Lee - CEO & Director Shawn M. Cross - Chief ...